UniCredit CEO Plots Commerzbank Governance Overhaul

NVIDIA CEO Jensen Huang Scandal

• Jensen Huang admitted to an affair with a woman identified in reports as a suspected Chinese spy (former Megaspeed International executive Alice Huang).
• Huang disclosed the relationship in a memo to employees and announced the company board is launching an investigation into potential information leaks.
• NVIDIA shares fell approximately 6% in pre-market trading, wiping out roughly $260 billion in market cap and returning stock levels to the year's low seen in March.
• The board is bringing in independent directors to investigate; Huang has stated he will fully cooperate with the inquiry.
• President Donald Trump publicly backed Huang, describing him as a "fine person" who has done an "incredible job," though internal and congressional scrutiny remains high.
• Key Man Risk: No clear succession plan exists; analyst notes Huang has 60 direct reports, creating a leadership vacuum if he is forced to step down.
• Geopolitical Implications: The scandal coincides with a scheduled US-China summit between Trump and Xi Jinping; concerns exist that Democrats and Republicans may unite to tighten chip export controls to China.
• Future Scrutiny: A House Committee on Foreign Affairs is scheduled to hold a closed-door session regarding the allegations on November 18.
• Investigation Scope: Reports suggest shell companies in Southeast Asia may have been used to funnel NVIDIA chips to China in violation of export controls.
• Market Impact: The news has created uncertainty regarding AI financing and data center rollout timelines, though some analysts view the sell-off as a "knee-jerk" reaction.

Global Market Reaction

• US Futures: NASDAQ futures initially dropped by 1.2% but recovered to near flat/negative territory as the day progressed; S&P 500 and Nasdaq were in negative territory on Friday.
• Asia Tech: A bifurcation emerged where the Taiwan market rose 4% on retail buying and belief in Huang, while the South Korean Kospi fell due to intolerance for uncertainty.
• Oil Prices: Brent crude fell 1.4% to below $97/barrel, providing potential support for European equities and consumer sectors.
• European Banking:
  • Unicredit reported record quarterly profits, lifting full-year guidance and boosting shares by nearly 5%.
  • Unicredit CEO Andrea Orcel indicated plans to implement "Commerzbank Unlocked" governance reforms as early as Q1 2027.
  • Credit Agricole proposed a merger with Banco BPM at a 20% premium, causing Banco BPM shares to surge over 11%.
  • Credit Agricole's own shares declined slightly as the market weighed the capital impact of the deal.
• Sector Performance:
  • Technology: Mixed performance; ASML shares were initially the biggest point drag but rebounded to positive territory.
  • Pharma: Sector outperformed; Novo Nordisk, AstraZeneca, and Sandoz saw gains.
  • Luxury: LVMH and the broader luxury sector declined by over 2% amid risk-off sentiment.
  • Energy: Travel and leisure sectors gained on lower oil prices.

ECB Leadership Succession

• Official applications for the ECB presidency closed on Friday, leaving two frontrunners: Klaus Rott (Netherlands) and Pablo Hernández de Cos (Spain).
• The European Central Bank faces a broader executive board reshuffle with three seats vacating in early 2026, prompting a "grand bargain" discussion among member states.
• Politicization Concerns: Christine Lagarde's early departure has raised questions about whether it was a strategic move to allow French President Macron to select her successor rather than a government led by Marine Le Pen or Jean-Luc Mélençon.
• Nadia Calvino: The President of the European Investment Bank (EIB) was mentioned as a potential late entrant into the race.
• EIB Strategy: Calvino announced a €10 billion expansion of the European Tech Champions initiative to close the gap with US and Chinese tech sectors.
• Defense Spending: The EIB is increasing its focus on security and defense financing, with plans to exceed 5% of total EU financing in these areas by year-end.

Trade and Geopolitical Developments

• China-US Trade Truce: China suspended an additional 24% tariffs on US goods for two months, extending the truce until January 10, while retaining a 10% blanket tariff.
• Trump-Xi Summit: A third summit between the two leaders is scheduled for the APEC gathering in Shenzhen later this month.
• Russia-Ukraine War: Hacker groups released data to Bloomberg suggesting Russia has recorded approximately 400,000 military deaths since the full-scale invasion began.
• Israeli Politics: President Isaac Herzog tasked opposition leader Gadi Ashkenazi with forming the next government after winning more lawmaker endorsements than Prime Minister Netanyahu.

Economic Data and Policy Outlook

• US Inflation: Investors are awaiting Tuesday's US CPI print to guide Federal Reserve rate hike expectations; current pricing suggests an 80% chance of a hike in December.
• Fed Policy: Analysts debate whether the Fed is behind the curve on inflation; while labor data remains strong, energy prices are moderating.
• Trade Resilience: HSBC's Global Pulse survey indicates over 85% of companies plan to expand trade despite energy cost pressures, with AI-driven hardware demand filling order books for 12-18 months.
• Forward-Looking Risks:
  • Potential slowdown in the AI build-out due to political shifts in Washington and the NVIDIA scandal, though momentum is expected to continue over a longer timeline.
  • Long-term fiscal risks in 2028 due to potential deficits and debt levels.
  • Continued volatility in energy markets dependent on US-Iran negotiations and the stability of the Red Sea shipping routes.

Additional Corporate Developments

• OpenAI: Closed a funding round of approximately $11 billion, valuing the company at $1.25 trillion, with potential for the round to reach $20 billion.
• Sandoz: Shares rose over 1% after its weight-loss drug semaglutide received approval for use in Brazil.
• Rating Changes: SAP shares gained nearly 2% after a J.P. Morgan upgrade and price target increase to €275; Fresenius Medical and Sharp were downgraded by Barclays and UBS, respectively.
• Hochtief: Shares fell over 4% after the Spanish owner ACS denied rumors of a takeover of its German subsidiary.